1. Home
  2. JRSH vs SCYX Comparison

JRSH vs SCYX Comparison

Compare JRSH & SCYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JRSH
  • SCYX
  • Stock Information
  • Founded
  • JRSH 2016
  • SCYX 1999
  • Country
  • JRSH United States
  • SCYX United States
  • Employees
  • JRSH 5600
  • SCYX N/A
  • Industry
  • JRSH Apparel
  • SCYX Biotechnology: Pharmaceutical Preparations
  • Sector
  • JRSH Consumer Discretionary
  • SCYX Health Care
  • Exchange
  • JRSH Nasdaq
  • SCYX Nasdaq
  • Market Cap
  • JRSH 38.5M
  • SCYX 36.8M
  • IPO Year
  • JRSH 2018
  • SCYX 2014
  • Fundamental
  • Price
  • JRSH $3.21
  • SCYX $0.81
  • Analyst Decision
  • JRSH
  • SCYX
  • Analyst Count
  • JRSH 0
  • SCYX 0
  • Target Price
  • JRSH N/A
  • SCYX N/A
  • AVG Volume (30 Days)
  • JRSH 133.6K
  • SCYX 214.4K
  • Earning Date
  • JRSH 06-23-2025
  • SCYX 08-07-2025
  • Dividend Yield
  • JRSH 6.23%
  • SCYX N/A
  • EPS Growth
  • JRSH N/A
  • SCYX N/A
  • EPS
  • JRSH N/A
  • SCYX N/A
  • Revenue
  • JRSH $138,135,034.00
  • SCYX $2,630,000.00
  • Revenue This Year
  • JRSH $29.89
  • SCYX $463.61
  • Revenue Next Year
  • JRSH $8.30
  • SCYX $310.80
  • P/E Ratio
  • JRSH N/A
  • SCYX N/A
  • Revenue Growth
  • JRSH 15.70
  • SCYX N/A
  • 52 Week Low
  • JRSH $2.68
  • SCYX $0.72
  • 52 Week High
  • JRSH $4.17
  • SCYX $2.29
  • Technical
  • Relative Strength Index (RSI)
  • JRSH 51.47
  • SCYX 42.55
  • Support Level
  • JRSH $3.08
  • SCYX $0.85
  • Resistance Level
  • JRSH $3.29
  • SCYX $0.95
  • Average True Range (ATR)
  • JRSH 0.10
  • SCYX 0.08
  • MACD
  • JRSH -0.00
  • SCYX -0.00
  • Stochastic Oscillator
  • JRSH 52.63
  • SCYX 29.17

About JRSH Jerash Holdings (US) Inc.

Jerash Holdings (US) Inc along with its subsidiaries is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers namely Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, Speedo etc. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

Share on Social Networks: